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Abstract
Membranes enriched in sarcolemma from the cross-striated adductor muscle of the deep sea scallop have been found to
contain a previously undescribed small protein of 6^8 kDa that can be released by treatment with organic solvent mixtures.
This proteolipid co-purified with a non-amino acid chromophore containing a conjugated trienoic moiety. Although
common in plants and algae, such a stable conjugated trienoic group is unusual for an animal cell. The N-terminal amino
acid sequence of the protein was XEFQHGLFGXF/ADNIGLQ, which most strongly resembles sequences in the triacyl
glycerol lipase precursor and the product of the human breast cancer susceptibility gene BRCA 1, but does not show
similarity to previously described proteolipids. The protein was found to be one of the major substrates in its parent
membrane for the catalytic subunit of protein kinase A, which may imply a regulatory function for this molecule. ß 1999
Elsevier Science B.V. All rights reserved.
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1. Introduction
Proteolipids are operationally de¢ned as proteins
soluble in organic solvents [1,2]. Small proteolipids
with an amphipathic organization have been found
in muscle. These include sarcolipin and phospholam-
ban of the sarcoplasmic reticulum, which are in-
volved in regulation of the SERCA1 and 2a isoforms
of the Ca2-ATPase of the sarcoplasmic reticulum
[3^6]. Phospholemman, found in cardiac sarcolemma
[7], has similarities to the proteolipid Q-subunit of the
Na,K-ATPase (e.g. [8^10]), which may regulate
certain steps of the pumping cycle of that enzyme
[11,12].
The cross-striated (phasic) part of scallop adductor
muscle has been the subject of many biochemical,
physiological, and structural investigations. Thus,
very extensive studies have been made of myosin-
linked regulation in the adductor muscle (e.g. [13]);
and the Ca2-transporting ATPase of the sarcoplas-
mic reticulum (SR) membrane has also been exam-
ined (e.g. [14,15]). Foot-type structures probably re-
lated to ryanodine Ca2-release channels have been
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observed in scallop muscle membrane preparations
[16]. However, the biochemistry of the sarcolemma
of the scallop muscle cell remains essentially unde-
scribed. In a preliminary study of scallop sarcolem-
ma, we have observed that preparations enriched in
that membrane possess a very distinctive near UV
spectrum typical of a conjugated triene moiety, and
that this is associated with a small protein extract-
able in organic solvents. This protein is one of the
major substrates in the membrane for protein kinase
A (PK-A).
2. Materials and methods
Deep sea scallops (Placopecten magellanicus) were
obtained from the Marine Biology Laboratory,
Woods Hole, MA. All chemicals were ACS grade
or better.
2.1. FSR, enriched SL, and deoxycholate-extracted
SR
The cross-striated part of the adductor muscle of
the deep sea scallop was ¢rst dissected and freed of
any other tissue, and the membrane fractions then
prepared from it essentially as described previously
[17,18].
2.2. Preparation of the proteolipid
The procedure initially followed that for the prep-
aration of scallop adductor muscle membrane frac-
tions as described previously [17,18]. The material
banding at the 0.32^0.8 M sucrose interface was col-
lected, and washed free of sucrose into a solution of
50 mM ammonium acetate, pH 6.8. Twenty volumes
of CHCl3^MeOH, 2:1, v/v, were then added to yield
a single phase. The preparation was centrifuged at
104Ug for 1 h, the supernatant carefully collected,
and ¢ltered under vacuum through three layers of
Whatman no. 1 ¢lter paper on a ¢ne glass sinter.
Three volumes of 50 mM ammonium acetate, pH
6.8, were then added to give two phases, and the
emulsion was centrifuged at 104Ug for 1 h. The
aqueous/MeOH upper layer containing the proteolip-
id was collected and subjected to rotary evaporation
to remove MeOH, after which the solution was di-
luted 2-fold with water and freeze-dried. (The pro-
teolipid could also be precipitated from the initial
CHCl3^MeOH extract with 5 vol. ice-cold diethyl
ether, and collected by centrifugation at 1^2000Ug
in glass tubes.) The freeze-dried material was dis-
solved in 50 mM ammonium acetate, pH 6.8, and
passed through a 1U8 cm column of Sephadex G-
50 (¢ne) in the same solvent to remove contaminat-
ing water-soluble small molecules, such as sucrose,
when it emerged in the void volume (probably in
the form of large mixed micelles with glycolipids
and lysophospholipids that also partition into the
aqueous phase). To further purify the proteolipid
from glycolipids, three volumes of ice-cold acetone
were then added, and after 30 min at 320‡C to allow
the precipitate to coagulate, the preparation was
centrifuged at 2000Ug at 4‡C for 5 min. The pellet
was washed with ice-cold acetone and dried in a
gentle stream of argon. The dried acetone precipitate
was dissolved in water, and extracted twice with
3 volumes of water-saturated 1-butanol. The lower
aqueous phase contained the conjugated trienoic
chromophore and proteolipid. Final puri¢cation
was by TLC on silicic acid using as mobile phase
1-propanol^H2O, 7:3, v/v (when the proteolipid has
an Rf of 0.47), or CHCl3^MeOH^H2O, 5:7:1, v/v/v
(when the proteolipid remains at the origin.). The
molecule was eluted from the scraped silica with
CHCl3^MeOH^2.5 M NH4OH, 60:40:9, v/v/v. The
puri¢ed material was stored dry under argon at
380‡C.
2.3. Electrophoresis
Polyacrylamide gel electrophoresis in SDS used the
Tris-Tricine system [19].
2.4. Protein determinations
This was by the bicinchoninic acid method [20].
2.5. Carbohydrate determination
Neutral hexose was assayed by the phenol-sulfuric
acid method [21]. Bial’s reagent (0.9% w/v FeCl3,
0.55% w/v orcinol in acidi¢ed ethanol) was used as
a spray reagent for qualitative detection of sugar on
TLC.
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2.6. Organic phosphorus
This was determined by the method of Bartlett
[22].
2.7. Total cholesterol (cholesterol and cholesterol
esters)
This was determined by a coupled enzyme proce-
dure using cholesterol esterase, cholesterol oxidase
and peroxidase [23].
2.8. N-terminal amino acid sequencing
One proteolipid preparation was adsorbed onto
Immobilon-P (Millipore), and sent to the Protein
Chemistry Laboratory, Washington University. A
second sample was reacted with Sequelon DITC-
and arylamine-derivatized PVDF discs, essentially
according to the protocols supplied by PerSeptive
Biosystems. Sequencing of the samples bound
through amino groups to the DITC membranes,
and through carboxyl groups to the arylamine mem-
branes was carried out simultaneously, to allow com-
plementary compensation for loss of coupled resi-
dues to the two di¡erent types of membrane. N-
Terminal sequencing of this sample was carried out
at the University of Florida Protein Core.
2.9. Treatment with protein kinase A
SL and SR (0.4 mg) were incubated at 23‡C for 1.5
min in a medium of 0.32 M sucrose, 0.1 M KCl, 0.1
mM [Q-32P]ATP (500 cpm pmol31), 2 mM DTT, 35
mM NaF, 5 mM MgCl2, 0.1 mM CaCl2, 5 mM
EGTA, 20 mM MOPSNa, pH 7.0 in a volume of
120 Wl with 18 U of the catalytic subunit of PK-A
(Sigma). The phosphorylation was stopped by add-
ing 2UTricine gel sample denaturation bu¡er. Gels
were run in the Tricine system, and dried onto What-
man no. 1 ¢lter paper, and autoradiography carried
out.
2.10. Ca2+-ATPase activity
This was measured as described previously [17].
2.11. Na+,K+-ATPase activity
This was measured as described previously [24].
Fig. 1. Polypeptide composition of the B1 and FSR membrane fractions. (A) Tricine SDS-PAGE with a 5% stacking gel and 10% sep-
arating gel, stained with Coomassie brilliant blue R-250. Lane a, B1 fraction (enriched SL) (15 Wg); lane b, deoxycholate-extracted SR
(membranous Ca-ATPase) (40 Wg); lane c, FSR (50 Wg); lane d, cyanogen bromide fragments of myoglobin, and glucagon (Sigma) (4
Wg). PLP, proteolipid. (B) Tricine SDS-PAGE using a 5% stacking gel, 10% intermediate gel, and 16.5% separating gel. Lane a, myo-
globin fragments (Sigma); lane b, enriched SL (21 Wg). PLP, proteolipid.
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3. Results
3.1. Preliminary characterization of a membrane
fraction enriched in sarcolemma
The membrane fraction (B1) used subsequently to
prepare the proteolipid was collected from the 0.32^
0.8 M sucrose interface. It had a greater ouabain-
inhibitable Na,K-ATPase activity, lower Ca2-
ATPase activity and higher cholesterol content than
the denser FSR fraction (Table 1). Comparison of
SDS gels of the B1 and FSR membrane fractions
(Fig. 1A) indicated that the 110-kDa band of the
Ca2-ATPase of the SR was decreased in intensity
in the B1 fraction relative to other components, in
particular to the polypeptide of MrV28 kDa previ-
ously noted [17]. Examination of the B1 fraction by
negative staining in the electron microscope showed
mainly sheet-like membranous structures (not
shown), very di¡erent from the well-described vesic-
ular scallop FSR [25,26]. Thin ¢laments were some-
times seen, and the band on SDS gels at 42 kDa is
probably actin. Thus, the B1 fraction is enriched in
SL, but still contaminated by elements of the SR and
thin ¢laments.
3.2. The enriched SL contains a 6^8-kDa protein and
a conjugated trienoic chromophore
When the enriched SL fraction (B1) was run on
Tricine gels with only a 5% stacking gel and 10%
separating gel, but no 16.5% layer, a relatively dif-
fuse, irregular, distorted band with a mobility corre-
sponding to 6^8 kDa could be seen (Fig. 1A, lane a).
This was present in signi¢cantly smaller amounts in
the FSR fraction (Fig. 1A, lane c), and is almost
absent from the deoxycholate-extracted SR (puri¢ed
membranous Ca2-ATPase) (Fig. 1A, lane b). On
Tricine gels with an additional 16.5% separating
layer, the 6^8 kDa band could be seen more clearly
(Fig. 1B). The near UV spectrum of the enriched SL
preparation displayed strong absorption peaks at
260, 271 and 282 nm (Fig. 2A), suggesting the pres-
ence of a conjugated triene [27].
Table 1
Comparison of scallop muscle membrane fractions
Enriched SL FSR
Ca2-ATPase activity (Wmol ATP min31 mg protein31) 0.32 þ 0.1 3.2 þ 0.4
% of Ca2-ATPase sensitive to oligomycin 2 þ 1 13 þ 4
Ouabain-inhibitable Na,K-ATPase activity (Wmol ATP min31 mg protein31) 0.19 þ 0.03 0.09 þ 0.02
Organic phosphorus (Wmol P mg protein31) 1.7 þ 0.1 1.10 þ 0.04
Cholesterol and cholesterol esters (Wmol mg protein31) 0.9 þ 0.1 0.30 þ 0.04
Each value is the mean and standard deviation of four measurements.
Fig. 2. Near UV spectra of the enriched sarcolemmal fraction
and the proteolipid. (A) Enriched SL was prepared as described
in Section 2 and dissolved in 1% w/v SDS, 20 mM MOPSNa,
pH 7.0, to a ¢nal total protein concentration of 0.6 mg ml31.
(B) Proteolipid dissolved in 1% w/v SDS, 20 mM MOPSNa,
pH 7.0, to a ¢nal protein concentration of 0.03 mg ml31.
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When the whole aqueous phase from the organic
solvent extraction step was freeze-dried and dissolved
in Tricine gel sample denaturation bu¡er, only a sin-
gle, distorted, Coomassie blue-stained band was seen
on SDS gels, with a mobility corresponding to 6^8
kDa (Fig. 3A). Thin layer chromatography on silicic
acid with solvents of intermediate polarity (e.g.
CHCl3^MeOH^H2O, 14:6:1, v/v/v) gave only a sin-
gle spot at the origin that charred with 40% v/v
H2SO4 on heating. However, TLC in solvents of
higher polarity, such as 1-propanol^H2O, 7:3, v/v
or CHCl3^MeOH^H2O, 5:7:1, v/v/v, revealed at
least seven other components besides the proteolipid.
Thus, while the partitioning step very e⁄ciently sep-
arated the proteolipid from the bulk of the lipid,
further puri¢cation as described in Section 2 was
necessary to remove more polar contaminants.
(These non-proteolipid species were not investigated
further in this work.) The proteolipid spot of Rf 0.47
(in 1-propanol^H20, 7:3, v/v) was stained with I2,
consistent with an unsaturated grouping being asso-
ciated with the protein.
After TLC puri¢cation, the proteolipid band on
SDS gels was sharper (Fig. 3B). The near UV ab-
sorption spectra of the proteolipid resembled that of
the B1 membrane fraction, with three prominent ab-
sorption bands having maxima at 260, 270.8 and 282
Fig. 3. Proteolipid prepared from a membrane fraction enriched in sarcolemma. Tricine SDS gels with 5% upper gel layer; 10% mid-
dle gel layer; 16.5% separating gel layer. (A) Aqueous phase from organic solvent extraction after freeze-drying. Lanes a and b, 3 Wg
proteolipid; lane c, myoglobin cyanogen bromide low molecular weight standards (Sigma). (B) Proteolipid after TLC puri¢cation.
Lane a, 5 Wg proteolipid; lane b, myoglobin cyanogen bromide low molecular weight standards (Sigma).
Table 2
N-Terminal amino acid sequence of the proteolipid
Cycle Sample 1 Sample 2
Residue Yield (pmol) Residue Yield (pmol)
1 ^ ^ ^ ^
2 E 28 E 12.95
3 F 55 F 15.45
4 Q 36 Q 14.61
5 ^ ^ H 4.53
6 G 33 G 7.51
7 L 36 L 11.33
8 F 34 F 9.09
9 G 37 G 5.84
10 ^ ^ ^ ^
11 F 39 A/F (1.02/0.62)
12 D 18 D 0.68
13 N 8 N 0.61
14 I 15 I 1.84
15 G 20 G 0.43
16 L 19 L 1.27
17 ^ ^ Q 0.80
18 ^ ^ (D) 0.20
19 ^ ^ A 0.90
20 ^ ^ I 0.42
Two separate samples of the proteolipid were prepared. One
sample (1) was adsorbed onto Immobilon-P, and the other
(sample 2) covalently reacted with DITC- and arylamine-deriv-
atized disks (see Section 2).
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nm (Fig. 2B), typical of a conjugated triene [27]. This
strongly absorbing chromophore obscures any ab-
sorption from the protein. Assuming an extinction
coe⁄cient of 5.7U104 M31 cm31 at 271 nm for the
conjugated triene [28], and that the protein does not
contribute signi¢cantly to the absorption spectrum,
the molecule contained a ratio of 1.2 þ 0.4 mol of
chromophore per 7 kDa protein (average of 4 meas-
urements), suggesting a possible stoichiometric rela-
tionship between the chromophore and the small
protein. One proteolipid preparation was adsorbed
onto Immobilon-P PVDF membrane; and a separate
preparation reacted with the DITC and arylamine
derivatized disks, as described in Section 2. The N-
terminal sequences from the two preparations shown
in Table 2 are in good agreement, and the probable
sequence is XEFQHGLFGXF/ADNIGLQ. Sugar
was detected qualitatively in the proteolipid band
on TLC by spraying with Bial’s reagent. When the
phenol-sulfuric acid carbohydrate assay was cali-
brated with an equimolar mixture of D-mannose
and D-galactose, it was found that there were 3.3
mol neutral hexose per mol 7 kDa protein (average
of three measurements). The material displayed some
unusual solubility properties. Very extensive washing
of the starting muscle membrane preparation with
aqueous media expected to extract peripheral mem-
brane proteins (e.g. 1 M KCl, 10 mM EDTA, 50
mM Na borate, pH 9.8) did not remove the protein,
but once released from the membrane, the molecule
could be dispersed in water, or dissolved in CHCl3^
MeOH^2.5 M NH4OH, 60:40:9, v/v/v. The chromo-
phore and protein were coprecipitated from water by
the addition of ammonium sulfate to 60% saturation
(4‡C).
3.3. Phosphorylation of the proteolipid by protein
kinase A
Treatment of the membrane fraction enriched in
SL (B1) and the FSR fraction with the catalytic sub-
unit of PK-A and [Q-P32]ATP led to the phosphoryl-
ation of a restricted number of proteins, as judged by
autoradiography of Tricine SDS gels (Fig. 4). Three
proteins were strongly phosphorylated in the en-
riched SL: the 110-kDa band, a 95-kDa band, and
the proteolipid. (An estimation of 32P incorporation
into protein partitioning into the aqueous phase after
chloroform^methanol extraction gave 0.4 mol per
7000 g protein.)
4. Discussion
Many otherwise highly unsaturated biological lip-
ids do not show conjugation amongst the double
bonds, which are usually separated by one methylene
group, although double bonds further apart can oc-
cur, e.g. in non-methylene-interrupted dienoic fatty
acids. Nevertheless, there are numerous reports of
stable conjugated trienes in plants and algae (e.g.
[29]). The eicosanoids and retinoids provide examples
of molecules with conjugated double bonds in ani-
mals. The retinoids are conjugated pentaenes, further
conjugated to carbonyl groups in retinal and retinoic
acid, and these compounds display electronic transi-
tions in the visible part of the spectrum, at longer
wavelengths than any absorption peak observed with
the scallop chromophore. Carotenoids, dietary pre-
cursors of the retinoids, show even more extensive
conjugation. In the case of eicosanoids, the lipoxyge-
nase pathways, in particular, give rise to many mol-
ecules containing conjugated double bonds (e.g. [27]),
such as hydroperoxy- and hydroxyeicosatetraenoic
acids (HPETE and HETE). The lipoxins (see [30]),
Fig. 4. Treatment of the SL and SR fractions with the catalytic
subunit of PK-A. The phosphorylations were carried out as de-
scribed in Section 2. Phosphorylated samples were run on Tri-
cine SDS gels with a 5% upper gel and a 12% separating gel.
Gels were dried onto ¢lter paper and exposed to Kodak X-
OMAT ¢lm. Lane a, FSR, 20 Wg; lane b, enriched SL, 20 Wg.
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produced by the action of more than one lipoxygen-
ase, have conjugated tetraene groups. The conju-
gated trienoic grouping itself is present in the leuko-
trienes, paracrine and autocrine mediators of
in£ammation and smooth muscle contraction pro-
duced by the lipoxygenase pathway in a variety of
immune cells. While polyunsaturated fatty acids in-
cluding 20:3, 20:4, 20:5 and 22:6 have been found in
marine bivalves, including the scallop [31], conjuga-
tion amongst the double bonds has not been re-
ported. Since the muscles used in the preparation
of the proteolipid were dissected out, cleaned, and
the sarcolemmal-enriched membrane fraction iso-
lated before the CHCl3^MeOH extraction step, it is
unlikely that the trienoic chromophore reported here
is derived from any direct algal contamination of the
tissue used as starting material. The chemical nature,
physiological role and biosynthetic origin of the
chromophore are of interest for further investigation.
The molecule to which the conjugated triene moiety
belongs may have a structural function, e.g. as a
non-polar anchor for the protein in the sarcolemmal
membrane. The deep sea scallop lives at a low am-
bient temperature [17], and the presence of the un-
saturated group may re£ect the need to maintain
membrane £uidity under such extreme conditions.
The conjugated grouping may be synthesized by the
scallop itself, or originate in the diet, possibly in
algae, some of which are known to possess an iso-
merase able to convert unconjugated fatty acids into
conjugated trienes [29,32].
The solubility properties of the proteolipid are un-
usual, in that it apparently dissolves in both water
and, for example, CHCl3^MeOH^2.5 M NH4OH,
60:40:9, v/v/v. However, whether it forms a truly
monomeric solution in water, or is in the form of a
micellar-like state remains to be investigated. Lipo-
philin, the proteolipid of myelin which is ordinarily
insoluble in water, can be transferred from organic
solvents, such as 2-chloroethanol, into aqueous me-
dia by dialysis procedures [33]. Prior to TLC puri¢-
cation, the detergent-like nature of contaminating
glycolipids and lysophospholipids also extracted
into the aqueous phase may enhance dispersion of
the proteolipid in aqueous media.
The subcellular location of the scallop muscle pro-
teolipid remains to be determined more precisely.
Although the B1 membrane fraction used for the
preparation of the proteolipid was enriched in SL,
it still had some Ca2-ATPase activity, and therefore
must be contaminated by elements of the SR. In
turn, the FSR fraction has Na,K-ATPase activity,
and so must contain some membranes derived from
the SL. Nevertheless, since scallop FSR consistently
contained signi¢cantly less of the proteolipid, the
proteolipid is probably associated with the SL com-
ponent of the B1 fraction, or some specialized region
of the SR involved in making contact with the SL
that remains bound to fragments of that membrane
after disruption of the muscle. Although the scallop
muscle lacks transverse tubules, it has junctions be-
tween the SL and cisternae of the underlying SR
which resemble the contacts between the transverse
tubules and terminal cisternae of vertebrate skeletal
muscle SR [34], and ryanodine type Ca2 release
channels have been found [16]. Presumably, the
patches of SL of the scallop cross-striated muscle
cell overlying these junctions ful¢l some of the func-
tions of transverse tubules of vertebrate cross-stri-
ated cells. Transverse tubules of vertebrate cross-stri-
ated muscle membranes possess a 28-kDa protein
[35], and the presence of a prominent 28-kDa band
on SDS gels of the scallop B1 membrane fraction
raises the possibility that the latter may contain
structures derived from the junctional region between
the SL and SR. Future studies will require detailed
subfractionation and investigation of the enriched SL
preparation. The presence of carbohydrate implies
that at least part of the proteolipid faces the external
medium, or an internal lumen.
Comparison of the N-terminal amino acid se-
quence of the scallop proteolipid with known sequen-
ces using the EMBL data base (‘Blitz’), indicated a
modest similarity to residues 15^24 of the triacylglyc-
erol lipase precursor (46% match), and to residues
1226^1240 of the human breast cancer susceptibility
gene product BRCA 1 (43% match), but it did not
match sequences from any of the previously de-
scribed proteolipids. The fact that the proteolipid
can be phosphorylated in situ in its parent membrane
by PK-A indicates that at least the part of the pro-
teolipid polypeptide chain containing a phosphory-
latable serine/threonine is exposed on one of the sur-
faces of the parent membrane, and accessible to the
kinase. Phosphorylation of phospholamban by PK-A
mediates the e¡ect of cAMP on the SERCA2a iso-
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form of SR Ca2-ATPase (e.g. [6]), and the function
of that proteolipid is well understood. Recent studies
indicate a possible role for sarcolipin as a physiolog-
ical regulator of SERCA1, the isoform of the Ca2-
ATPase expressed in skeletal muscle [5]. Two isopro-
teolipids may modulate the H-ATPase activity of
the plasma membrane of Saccharomyces cerevisiae
[36,37]. The physiological role of the relatively well-
studied Q-subunit of the Na,K-ATPase, has not
been clear [10,24]; but recent studies suggest that it
may modulate the K-activation of the Na,K-
ATPase [11], and be involved in the occlusion of
K by that enzyme [12]. The function of phospho-
lemman, a proteolipid present in cardiac sarcolemma
[7] which has a 52% amino acid sequence identity
with the Q-subunit of the Na,K-ATPase, remains
unclear. However, it is known to be a major sub-
strate for PK-A, and so, like the Q-subunit, phospho-
lamban, sarcolipin and the H-ATPase proteolipids,
may form part of a regulatory mechanism. Like
phospholemman, the function of the proteolipid
from scallop muscle is at present unknown, but
may be regulatory.
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